Variation in cystic fibrosis newborn screening algorithms in the United States
Pediatric Pulmonology · 2023-03 · 58 (3) · 927-933
DOI: 10.1002/ppul.26279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 16.12.2022. Verfasst von Maryann R Rehani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Milken Institute of Public Health, George Washington University, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Rationale
Cystic fibrosis (CF) newborn screening (NBS) algorithms in the United States vary by state. Differences in CF NBS algorithms could potentially affect the detection rate of CF newborns and lead to disparities in CF diagnosis amongst different racial and ethnic groups.
Objectives
Generate a database of CF NBS algorithms in the United States and identify processes that may potentially lead to missed diagnoses or lead to healthcare disparities.
Methods
We sent an online survey to state and regional CF and NBS leaders about the type and threshold of immunoreactive trypsinogen (IRT) cutoff used and methods used for CFTR gene variant analysis. Follow‐up by email and phone was done to ensure a response from every state, clarify responses, and resolve discordances .
Results
There is wide variation in the NBS algorithms employed by different states. Approximately half the states use a floating IRT cutoff, and half use a fixed IRT cutoff. CFTR variant analysis also varies widely, with two states analyzing only for the F508del variant and four states incorporating CFTR gene sequencing. The other states use CFTR variant panels ranging from 23 to 365 CFTR variants.
Conclusions
CF NBS algorithms vary widely amongst the different states in the United States, which affects the ability of CF NBS to diagnose newborn infants with CF consistently and uniformly across the country and potentially may miss more infants with CF from minority populations. Our results identify an important area for quality improvement in CF NBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Milken Institute of Public Health, George Washington University, Washington, District of Columbia, USA.
- Madison Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
- School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Philip M Farrell, Clement L Ren
Förderung
- Cystic Fibrosis Foundation
Zitieren
APA
Rehani, M. R., Marcus, M. S., Harris, A. B., Farrell, P. M., & Ren, C. L. (2023). Variation in cystic fibrosis newborn screening algorithms in the United States. Pediatric Pulmonology, 58(3), 927-933. https://doi.org/10.1002/ppul.26279
Vancouver
Rehani MR, Marcus MS, Harris AB, Farrell PM, Ren CL. Variation in cystic fibrosis newborn screening algorithms in the United States. Pediatric Pulmonology. 2023;58(3):927-933. doi:10.1002/ppul.26279
BibTeX
@article{Rehani2023,
author = {Rehani, Maryann R and Marcus, Mary S and Harris, Anne B and Farrell, Philip M and Ren, Clement L},
title = {Variation in cystic fibrosis newborn screening algorithms in the United States},
journal = {Pediatric Pulmonology},
year = {2023},
volume = {58},
number = {3},
pages = {927--933},
doi = {10.1002/ppul.26279}
}
EUVIMED